Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03123783
Title CD40 Agonistic Antibody APX005M in Combination With Nivolumab
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Apexigen, Inc.
Age Groups: senior | adult
Covered Countries USA | ESP

No variant requirements are available.